O

Oragenics
D

OGEN

0.37000
USD
0.01
(2.78%)
Market Closed
Volume
1,498
EPS
-11
Div Yield
-
P/E
-0
Market Cap
4,526,832
OverviewSignalsIdeasNews
Related Instruments
    O
    OBE
    0.04500
    (0.89%)
    5.10000 USD
    O
    OESX
    -0.05310
    (-6.44%)
    0.77160 USD
    O
    OGE
    0.285
    (0.69%)
    41.300 USD
    O
    OVBC
    0.650
    (2.62%)
    25.450 USD
    More
News

Title: Oragenics

Sector: Healthcare
Industry: Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.